Research Article
Have access already?
Get access to this article:
Or get access to the particular issue:
- Perpetual access Add to cart ($49.95)
Or get access to the entire journal:
Abstract
Two studies balanced qualitative and quantitative data to provide evidence of satisfactory validity and reliability of the Family Inventory of Needs (FIN). The FIN is designed to measure the importance of care needs of families of advanced cancer patients (FIN-Importance of Care Needs subscale) and the extent to which families perceive that their care needs have been met (FINFulfillment of Care Needs subscale). The first study involved development of the instrument and testing for clarity, apparent internal consistency (nonquantitative assessment of homogeneity of content), and content validity using a panel of six experts (family members of advanced cancer patients). The FIN met or exceeded the preset criteria specified used in this phase of testing. The second study of the project used 109 family members of advanced cancer patients from three hospice programs to test the FIN for internal consistency and construct validity. Internal consistency of the FIN-Importance of Care Needs subscale as measured by Cronbach’s alpha coefficient was .83 without redundancy. Construct analysis was assessed using factor analysis techniques. An inability to extract a substantively meaningful minimum number of factors, together with the fact that a theta reliability coefficient of .85 was obtained (only .02 higher than the alpha coefficient), suggested that the items were parallel supporting the conclusion that the subscale is unidimensional. Support for the construct validity of the FINImportance of Care Needs subscale was also obtained using predictive modeling. The internal structure of the FIN-Fulfillment of Care Needs subscale was assessed using cluster analysis. Results suggested that the subscale is a unidimensional one. Overall, the FIN met the preset reliability and validity criteria providing promising evidence for the instrument’s sound psychometric properties for use in research and clinical settings.
Period | Abstract | Full | Total | |
---|---|---|---|---|
Apr 2024 | 11 | 0 | 0 | 11 |
Mar 2024 | 12 | 0 | 2 | 14 |
Feb 2024 | 14 | 0 | 0 | 14 |
Jan 2024 | 21 | 0 | 0 | 21 |
Dec 2023 | 9 | 0 | 0 | 9 |
Nov 2023 | 26 | 0 | 0 | 26 |
Oct 2023 | 19 | 0 | 1 | 20 |
Sep 2023 | 47 | 0 | 2 | 49 |
Aug 2023 | 3 | 0 | 0 | 3 |
Jul 2023 | 15 | 0 | 0 | 15 |
Jun 2023 | 14 | 0 | 0 | 14 |
May 2023 | 17 | 0 | 0 | 17 |
Apr 2023 | 33 | 0 | 0 | 33 |
Mar 2023 | 14 | 0 | 0 | 14 |
Feb 2023 | 26 | 0 | 0 | 26 |
Jan 2023 | 55 | 0 | 0 | 55 |
Dec 2022 | 39 | 0 | 0 | 39 |
Nov 2022 | 45 | 0 | 0 | 45 |
Oct 2022 | 23 | 0 | 0 | 23 |
Sep 2022 | 18 | 0 | 0 | 18 |
Aug 2022 | 7 | 0 | 0 | 7 |
Jul 2022 | 14 | 0 | 0 | 14 |
Jun 2022 | 27 | 0 | 0 | 27 |
May 2022 | 58 | 0 | 0 | 58 |
Apr 2022 | 21 | 0 | 0 | 21 |
Mar 2022 | 22 | 0 | 0 | 22 |
Feb 2022 | 5 | 0 | 1 | 6 |
Jan 2022 | 19 | 0 | 0 | 19 |
Dec 2021 | 14 | 0 | 0 | 14 |
Nov 2021 | 47 | 0 | 0 | 47 |
Oct 2021 | 23 | 0 | 1 | 24 |
Sep 2021 | 16 | 0 | 0 | 16 |
Aug 2021 | 32 | 0 | 1 | 33 |
Jul 2021 | 26 | 0 | 0 | 26 |
Jun 2021 | 29 | 0 | 0 | 29 |
May 2021 | 8 | 0 | 0 | 8 |
Apr 2021 | 11 | 0 | 0 | 11 |
Mar 2021 | 24 | 0 | 0 | 24 |
Feb 2021 | 64 | 0 | 0 | 64 |
Jan 2021 | 42 | 0 | 0 | 42 |
Dec 2020 | 34 | 0 | 0 | 34 |
Nov 2020 | 88 | 0 | 0 | 88 |
Oct 2020 | 66 | 0 | 1 | 67 |
Sep 2020 | 22 | 0 | 0 | 22 |
Aug 2020 | 32 | 0 | 1 | 33 |
Jul 2020 | 14 | 0 | 0 | 14 |
Jun 2020 | 7 | 0 | 0 | 7 |
May 2020 | 35 | 0 | 4 | 39 |
Apr 2020 | 7 | 0 | 1 | 8 |
Mar 2020 | 16 | 0 | 0 | 16 |
Feb 2020 | 48 | 0 | 2 | 50 |
Jan 2020 | 30 | 0 | 1 | 31 |
Dec 2019 | 23 | 0 | 0 | 23 |
Nov 2019 | 11 | 0 | 0 | 11 |
Oct 2019 | 21 | 0 | 0 | 21 |
Sep 2019 | 29 | 0 | 1 | 30 |
Aug 2019 | 4 | 0 | 0 | 4 |
Jul 2019 | 27 | 0 | 1 | 28 |
Jun 2019 | 24 | 0 | 0 | 24 |
May 2019 | 26 | 0 | 0 | 26 |
Apr 2019 | 24 | 0 | 0 | 24 |
Mar 2019 | 59 | 0 | 0 | 59 |
Feb 2019 | 36 | 0 | 0 | 36 |
Jan 2019 | 46 | 0 | 1 | 47 |
Dec 2018 | 20 | 0 | 0 | 20 |
Nov 2018 | 47 | 0 | 2 | 49 |
Oct 2018 | 22 | 0 | 5 | 27 |
Sep 2018 | 21 | 0 | 0 | 21 |
Aug 2018 | 16 | 0 | 0 | 16 |